The aim of the present study was to evaluate whether enhanced asthma-related TGF-β1 FMT is the result of the differential activation of the profibrotic TGF-β/Smad2/3 and antifibrotic TGF-β/Smad1/5/9 signalling pathways in HBFs. This evidence concerns the gene SMAD1 and asthma.